Article Details
Retrieved on: 2025-01-22 06:47:55
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article primarily focuses on analysts' revised ratings and target prices for various companies, including Netflix and several in the biopharma sector like Regeneron and Vertex Pharmaceuticals, amidst the broader financial market implications involving firms like Barclays and Morgan Stanley.
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here